Association of Mean Platelet Volume with Risk of Stroke among 3134 Individuals with History of Cerebrovascular Disease

Stroke

Volumn 35, Issue 3, 2004, Pages 622-626

  Bath, Philip ^a   Algert, Charles ^b   Chapman, Neil ^b   Neal, Bruce ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Myocardial infarction; Platelets; Stroke, hemorrhagic; Stroke, ischemic

Indexed keywords

PERINDOPRIL;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STROKE; THROMBOCYTE FUNCTION; THROMBOCYTE VOLUME; TRANSIENT ISCHEMIC ATTACK;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AUSTRALIA; BLOOD PLATELETS; CELL SIZE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; CHINA; COMORBIDITY; CORONARY DISEASE; DIURETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; JAPAN; MALE; MIDDLE AGED; MULTICENTER STUDIES; NEW ZEALAND; PERINDOPRIL; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RISK ASSESSMENT; SWEDEN;

EID: 1442274814     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000116105.26237.EC     Document Type: Article

References (30)

1. Martin JF, Bath PMW. Platelets and megakaryocytes in vascular disease. In: Herman AG, ed, Antithrombotics: pathophysiological rationale for pharmacological inventions. Dordrecht, Boston, Kluwer Academic Publishers; 1991:49-62.
2. Sharp DB, Bath PMW, Martin JF, et al. Cigarette smoking sensitizes and desensitizes impedance-measured ADP-induced platelet aggregation in whole blood. Thromb Haemost. 1995;74:730-735.
3. D'Erasmo E, Aliberti G, Celi F, et al. Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction. J Intern Med. 1990;227:11-14.
4. O'Malley T, Langhorne P, Elton R, et al. Platelet size in stroke patients. Stroke. 1995;26:995-999.
5. Butterworth R, Bath P. The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets. 1998;9:359-364.
6. Tohgi H, Suzuki H, Tamura K, et al. Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke. 1991;22:17-21.
7. Cameron HP, Ibbotson RM, Carson PHM. Platelet size in myocardial infarction. BMJ. 1983;287:449-451.
8. Kishk YT, Martin JF. Platelet volume subpopulations in acute myocardial infarction: an investigation of their homogeneity for smoking, infarct size and site. Clin Sci. 1985;68:419-425.
9. Bath PM, Buckenham T, MacGregor GA. Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clin Sci. 1994;87:253-257.
10. Endler G, Klimesch A, Sunder-Plassmann H, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002;117:399-404.
11. Lande K, Os I, Kjeldsen S, et al. Increased platelet size and release reaction in essential hypertension. J Hypertens. 1987;5:401-406.
12. Sharpe P, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med. 1993;86:739-742.
13. Martin J, Bath PMW, Burr ML. Increased platelet size following myocardial infarction is associated with subsequent death and non-fatal reinfarction. Lancet. 1991;338:1409-1411.
14. Pabon P, Nieto F, Morinigo J, et al. The effect of mean platelet volume on the short-term prognosis of acute myocardial infarction. Rev Esp Cardiol. 1998;51:816-822.
15. Smyth DM, Martin JF, Michalis L, et al. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest. 1993;23:361-367.
16. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
17. PROGRESS Management Committee. Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS. J Hypertens. 1996;14(suppl 2):S41-S46.
18. PROGRESS Management Committee. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): characteristics of the study population at baseline. J Hypertens. 1999;17:1647-1655.
19. Bath P. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost. 1993;70:687-690.
20. Jackson SC, Carter JM, Platelet volume: laboratory measurement and clinical application. Blood Review. 1993;7:104-113.
21. Clarke R, Shipley M, Lewingtion S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150:341-353.
22. Bath P, Butterworth R. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7:157-161.
23. del Zoppo G. The role of platelets in ischemic stroke. Neurology. 1998;51(suppl 3):S9-S14.
24. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
25. Trowbridge E, Reardon M, Hutchinson D, et al. The routine measurement of platelet volume: a comparison of light-scattering and aperture-impedance technologies. Clin Phys Physiol Meas. 1985;6:221-238.
26. Okrucka A, Pechan J, Kratochvilova H. Effects of the angiotensin-converting enzyme (ACE) inhibitor perindopril on endothelial and platelet functions in essential hypertension. Platelets. 1998;9:63-67.
27. Gupta RK, Motley E, Weder AB, et al. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor. J Cardiovasc Pharmacol. 1990;17:13-19.
28. Jagroop I, Mikhailidis D. Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. J Hum Hypertens. 2001;14:581-585.
29. Pathansali R, Smith NM, Bath PMW. Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study. Platelets. 2001;12:144-149.
30. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists and other blood pressure lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356:1955-1964.